Enhanced adenoviral gene delivery to motor and dorsal root ganglion neurons following injection into demyelinated peripheral nerves

Journal of Neuroscience Research

Volumn 88, Issue 11, 2010, Pages 2374-2384

  Zhang, Yongjie ^a   Zheng, Yiyan ^a   Zhang, Yi Ping ^b   Shields, Lisa B E ^b   Hu, Xiaoling ^a   Yu, Panpan ^a   Burke, Darlene A ^a   Wang, Heming ^c   Jun, Cai ^d   Byers, Jonathan ^a   Whittemore, Scott R ^a   Shields, Christopher B ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b Norton Healthcare   (United States)

^c NANJING MEDICAL UNIVERSITY   (China)

^d University of Louisville School of Medicine   (United States)

Author keywords

Adenovirus; Demyelination; DRG neuron; Motoneuron; Peripheral nerve

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; LYSOPHOSPHATIDYLCHOLINE; VIRUS RECEPTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL COUNT; CONTROLLED STUDY; COXSACKIE VIRUS; DEMYELINATION; FEMALE; GENE DELIVERY SYSTEM; GENE TARGETING; GENE TRANSFER; MOTONEURON; MOTOR SYSTEM; MOUSE; MYELIN SHEATH; NERVE FIBER; NONHUMAN; PAIN; PERIPHERAL NERVE; PRIORITY JOURNAL; SCIATIC NERVE; SPINAL CORD INJURY; SPINAL CORD VENTRAL HORN; SPINAL GANGLION; VIRUS ENTRY; ADENOVIRIDAE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DEMYELINATING DISEASE; ENTEROVIRUS; GENETICS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; METABOLISM; NERVE CELL; NEURITIS; PATHOLOGY; PHYSIOLOGY; SENSATION; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; DEMYELINATING DISEASES; ENTEROVIRUS; FEMALE; GANGLIA, SPINAL; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; LYSOPHOSPHATIDYLCHOLINES; MICE; MICE, INBRED C57BL; MOTOR NEURONS; NEURITIS; NEURONS; PERIPHERAL NERVES; RECEPTORS, VIRUS; SCIATIC NERVE; SENSATION;

EID: 77955411795     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22394     Document Type: Article

References (69)

1. Abdellatif AA, Pelt JL, Benton RL, Howard RM, Tsoulfas P, Ping P, Xu XM, Whittemore SR. 2006. Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems. J Neurosci Res 84:553-567. (Pubitemid 44196696)
2. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, Carmeliet P, Mazarakis ND. 2004. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429:413-417. (Pubitemid 38715132)
3. Bechtold DA, Kapoor R, Smith KJ. 2004. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol 55:607-616.
4. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
5. Blits B, Bunge MB. 2006. Direct gene therapy for repair of the spinal cord. J Neurotrauma 23:508-520. (Pubitemid 43726325)
6. Boulis NM, Turner DE, Dice JA, Bhatia V, Feldman EL. 1999. Characterization of adenoviral gene expression in spinal cord after remote vector delivery. Neurosurgery 45:131-137. (Pubitemid 29318883)
7. Boulis NM, Turner DE, Imperiale MJ, Feldman EL. 2002. Neuronal survival following remote adenovirus gene delivery. J Neurosurg 96:212-219.
8. Boulis NM, Noordmans AJ, Song DK, Imperiale MJ, Rubin A, Leone P, During M, Feldman EL. 2003a. Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery. Neurobiol Dis 14:535-541.
9. Boulis NM, Willmarth NE, Song DK, Feldman EL, Imperiale MJ. 2003b. Intraneural colchicine inhibition of adenoviral and adeno-associated viral vector remote spinal cord gene delivery. Neurosurgery 52:381-387.
10. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, Reier PJ, Mandel RJ, Muzyczka N. 2004. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 10:302-317.
11. Burton EA, Fink DJ, Glorioso JC. 2005. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications. Curr Opin Mol Ther 7:326-336.
12. Coggeshall RE, Lekan HA. 1996. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 364:6-15.
13. Davidson BL, Breakefield XO. 2003. Viral vectors for gene delivery to the nervous system. Nat Rev Neurosci 4:353-364. (Pubitemid 37280174)
14. Deglon N, Hantraye P. 2005. Viral vectors as tools to model and treat neurodegenerative disorders. J Gene Med 7:530-539.
15. Dodge JC, Clarke J, Song A, Bu J, Yang W, Taksir TV, Griffiths D, Zhao MA, Schuchman EH, Cheng SH, O'Riordan CR, Shihabuddin LS, Passini MA, Stewart GR. 2005. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease. Proc Natl Acad Sci U S A 102:17822-17827.
16. Farooque M, Isaksson J, Olsson Y. 2001. Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-alpha-deficient mice. J Neurotrauma 18:105-114. (Pubitemid 32055460)
17. Farooque M, Suo Z, Arnold PM, Wulser MJ, Chou CT, Vancura RW, Fowler S, Festoff BW. 2006. Gender-related differences in recovery of locomotor function after spinal cord injury in mice. Spinal Cord 44:182-187.
18. Fu H, Muenzer J, Samulski RJ, Breese G, Sifford J, Zeng X, McCarty DM. 2003. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther 8:911-917.
19. Ghadge GD, Roos RP, Kang UJ, Wollmann R, Fishman PS, Kalynych AM, Barr E, Leiden JM. 1995. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther 2:132-137.
20. Ghosh A, Yue Y, Duan D. 2006. Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle. J Gene Med 8:298-305.
21. Glatzel M, Flechsig E, Navarro B, Klein MA, Paterna JC, Bueler H, Aguzzi A. 2000. Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proc Natl Acad Sci U S A 97:442-447. (Pubitemid 30055850)
22. Glorioso JC, Fink DJ. 2004. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annu Rev Microbiol 58:253-271.
23. Gu Y, Xu Y, Li GW, Huang LY. 2005. Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine. J Pain 6:447-454.
24. Haase G, Kennel P, Pettmann B, Vigne E, Akli S, Revah F, Schmalbruch H, Kahn A. 1997. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med 3:429-436.
25. Haase G, Pettmann B, Vigne E, Castelnau-Ptakhine L, Schmalbruch H, Kahn A. 1998. Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanisms of action. J Neurol Sci 160(Suppl 1):S97-S105.
26. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. 1988. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
27. Hasegawa H, Abbott S, Han BX, Qi Y, Wang F. 2007. Analyzing somatosensory axon projections with the sensory neuron-specific Advillin gene. J Neurosci 27:14404-14414.
28. Hermens WT, Verhaagen J. 1998. Suppression of inflammation by dexamethasone prolongs adenoviral vector-mediated transgene expression in the facial nucleus of the rat. Brain Res Bull 47:133-140. (Pubitemid 28502854)
29. Hildebrandt C, Hahn R. 1978. Relation between myelin sheath thickness and axon size in spinal cord white matter of some vertebrate species. J Neurol Sci 38:421-434.
30. Hill RL, Zhang YP, Burke DA, Devries WH, Zhang Y, Magnuson DS, Whittemore SR, Shields CB. 2009. Anatomic and functional outcomes following a precise, graded, dorsal laceration spinal cord injury in C57BL/6 mice. J Neurotrauma 26:1-15.
31. Hollis ER, Kadoya K, Hirsch M, Samulski RJ, Tuszynski MH. 2008. Efficient retrograde neuronal transduction utilizing self-complementary AAV1. Mol Ther 16:296-301.
32. Huber AB, Ehrengruber MU, Schwab ME, Brosamle C. 2000. Adenoviral gene transfer to the injured spinal cord of the adult rat. Eur J Neurosci 12:3437-3442.
33. Iannotti C, Zhang YP, Shields LBE, Han Y, Burke DA, Xu XM, Shields CB. 2006. Dural repair reduces connective tissue scar invasion and cystic cavity formation after acute spinal cord laceration injury in adult rats. J Neurotrauma 23:853-865.
34. Jackson CA, Messinger J, Peduzzi JD, Ansardi DC, Morrow CD. 2005. Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10. Virology 336:173-183. (Pubitemid 40693952)
35. Jakobsson J, Lundberg C. 2006. Lentiviral vectors for use in the central nervous system. Mol Ther 13:484-493.
36. Jakobsson J, Ericson C, Jansson M, Bjork E, Lundberg C. 2003. Targeted transgene expression in rat brain using lentiviral vectors. J Neurosci Res 73:876-885.
37. Jani A, Menichella D, Jiang H, Chbihi T, Acsadi G, Kamholz J, Shy ME. 1999. Overcoming cellular immunity to prolong adenoviral-mediated gene expression in sciatic nerve. Ann N Y Acad Sci 883:397-414.
38. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. 2003. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301:839-842. (Pubitemid 36962626)
39. Keir SD, Mitchell WJ, Feldman LT, Martin JR. 1995. Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV-1 vector. J Neurovirol 1:259-267.
40. Kikuchi H, Doh-ura K, Kawashima T, Kira J, Iwaki T. 1999. Immunohistochemical analysis of spinal cord lesions in amyotrophic lateral sclerosis using microtubule-associated protein 2 (MAP2) antibodies. Acta Neuropathol 97:13-21.
41. Kim J, Smith T, Idamakanti N, Mulgrew K, Kaloss M, Kylefjord H, Ryan PC, Kaleko M, Stevenson SC. 2002a. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. J Virol 76:1892-1903.
42. Kim M, Zinn KR, Barnett BG, Sumerel LA, Krasnykh V, Curiel DT, Douglas JT. 2002b. The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer 38:1917-1926.
43. Kunkel-Bagden E, Dai HN, Bregman BS. 1993. Methods to assess the development and recovery of locomotor function after spinal cord injury in rats. Exp Neurol 119:153-164. (Pubitemid 23132012)
44. Kuo H, Ingram DK, Crystal RG, Mastrangeli A. 1995. Retrograde transfer of replication deficient recombinant adenovirus vector in the central nervous system for tracing studies. Brain Res 705:31-38.
45. Lai Y, Yue Y, Liu M, Ghosh A, Engelhardt JF, Chamberlain JS, Duan D. 2005. Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat Biotechnol 23:1435-1439.
46. Le Gal La SG, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M, Mallet J. 1993. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990. (Pubitemid 23080671)
47. Lisovoski F, Cadusseau J, Akli S, Caillaud C, Vigne E, Poenaru L, Stratford-Perricaudet L, Pericaudet M, Kahn A, Peschanski M. 1994. In vivo transfer of a marker gene to study motoneuronal development. Neuroreport 5:1069-1072.
48. Liu Y, Himes BT, Moul J, Huang W, Chow SY, Tessler A, Fischer I. 1997. Application of recombinant adenovirus for in vivo gene delivery to spinal cord. Brain Res 768:19-29.
49. Louboutin JP, Reyes BA, Agrawal L, Van BE, Strayer DS. 2007. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors. Gene Ther 14:939-949. (Pubitemid 46865505)
50. Mandel RJ, Manfredsson FP, Foust KD, Rising A, Reimsnider S, Nash K, Burger C. 2006. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol Ther 13:463-483.
51. Nakajima H, Uchida K, Kobayashi S, Kokubo Y, Yayama T, Sato R, Baba H. 2005. Targeted retrograde gene delivery into the injured cervical spinal cord using recombinant adenovirus vector. Neurosci Lett 385:30-35.
52. Nakajima H, Uchida K, Kobayashi S, Inukai T, Horiuchi Y, Yayama T, Sato R, Baba H. 2007. Rescue of rat anterior horn neurons after spinal cord injury by retrograde transfection of adenovirus vector carrying brain-derived neurotrophic factor gene. J Neurotrauma 24:703-712.
53. Persson A, Fan X, Salford LG, Widegren B, Englund E. 2007. Neuroblastomas and medulloblastomas exhibit more Coxsackie adenovirus receptor expression than gliomas and other brain tumors. Neuropathology. 27:233-236.
54. Pirozzi M, Quattrini A, Andolfi G, Dina G, Malaguti MC, Auricchio A, Rugarli EI. 2006. Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia. J Clin Invest 116:202-208. (Pubitemid 43121805)
55. Rabchevsky AG, Fugaccia I, Sullivan PG, Scheff SW. 2001. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J Neurotrauma 18:513-522.
56. Romero MI, Smith GM. 1998. Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade. Gene Ther 5:1612-1621.
57. Ruitenberg MJ, Eggers R, Boer GJ, Verhaagen J. 2002. Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system. Methods 28:182-194.
58. Ryan DA, Federoff HJ. 2007. Translational considerations for CNS gene therapy. Expert Opin Biol Ther 7:305-318.
59. Sims K, Ahmed Z, Gonzalez AM, Read ML, Cooper-Charles L, Berry M, Logan A. 2008. Targeting adenoviral transgene expression to neurons. Mol Cell Neurosci 39:411-417.
60. St. George JA. 2003. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 10:1135-1141.
61. Tallini YN, Shui B, Greene KS, Deng KY, Doran R, Fisher PJ, Zipfel W, Kotlikoff MI. 2006. BAC transgenic mice express enhanced green fluorescent protein in central and peripheral cholinergic neurons. Physiol Genomics 27:391-397. (Pubitemid 46708790)
62. Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, Mortelmans L, Wilson JM, Debyser Z, Baekelandt V. 2007. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 18:195-206.
63. Turner DE, Noordmans AJ, Feldman EL, Boulis NM. 2001. Remote adenoviral gene delivery to the spinal cord: contralateral delivery and reinjection. Neurosurgery 48:1309-1316.
64. Verma IM, Somia N. 1997. Gene therapy - promises, problems and prospects. Nature 389:239-242.
65. Watanabe TS, Ohtori S, Koda M, Aoki Y, Doya H, Shirasawa H, Yamazaki M, Moriya H, Takahashi K, Yamashita T. 2006. Adenoviral gene transfer in the peripheral nervous system. J Orthop Sci 11:64-69.
66. Wharton SB, Meyers NL, Nash AA. 1995. Experimental herpes simplex virus type 1 (HSV-1) infection of the spinal cord and dorsal root ganglia. Neuropathol Appl Neurobiol 21:228-237.
67. Willis WD, Coggeshall R. 1991. Dorsal root ganglion cells and their process. New York: Plenum. p 47-78.
68. Xu Y, Gu Y, Wu P, Li GW, Huang LY. 2003. Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Hum Gene Ther 14:897-906. (Pubitemid 36693798)
69. Yamamura J, Kageyama S, Uwano T, Kurokawa M, Imakita M, Shiraki K. 2000. Long-term gene expression in the anterior horn motor neurons after intramuscular inoculation of a live herpes simplex virus vector. Gene Ther 7:934-941.